Oh hey there…another Top 5 topics you need to know from outside Europe this week.
Enjoy and if you have time, give us some feedback!
HIV Tablet ‘Truvada‘: San Francisco health Insurance firm Kaiser Permanente published a study on Tuesday showed out of the 657 ‘high risk of HIV’ patients taking Truvada, none contracted HIV over a 3-year period marking a massive milestone in the battle against AIDS.
CRISPR-Cas9 genome editing complex delivered to cell nucleus by engineered extracellular DNA-based transport package dubbed ‘Nanoclews’. Shown to be an efficient delivery method of Cas9, it has been demonstrated both in vivo and in vitro.
“Scientists can now watch dynamic biological processes with unprecedented clarity in living cells using new imaging techniques.